We are gene therapy innovation leaders. We develop platforms to treat severe genetic disorders and cellular aging. We are working on several patents and are seeking strategic partnerships to help us make a positive step forward in our efforts to bring cures to aging populations and those who suffer monogenic disease. At the heart of Bioviva’s product creation efforts is it’s broadly applicable gene therapy platform for the development of novel one time treatments for diseases with either ineffective or no clinical options.